References
- Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266–81.
- Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 1983;57:1308–10.
- Bhalla AK, Amento EP, Serog B, Glimcher LH. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol 1984;133:1748–54.
- Koeffler HP, Amatruda T, Ikekawa N, Kobayashi Y, DeLuca HF. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res 1984;44:5624–8.
- Tobler A, Gasson J, Reichel H, Norman AW, Koeffler HP. Granulocyte-macrophage colony-stimulating factor. Sensitive and receptor-mediated regulation by 1,25-dihydroxyvitamin D3 in normal human peripheral blood lymphocytes. J Clin Invest 1987;79:1700–5.
- Bartels LE, Jorgensen SP, Agnholt J, Kelsen J, Hvas CL, Dahlerup JF. 1,25-dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+ T cells from patients with Crohn's disease. Int Immunopharmacol 2007;7:1755–64.
- Cozzolino M, Vidal M, Arcidiacono MV, Tebas P, Yarasheski KE, Dusso AS. HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D. AIDS 2003;17:513–20.
- Fawzi WW, Msamanga GI, Spiegelman D, Wei R, Kapiga S, Villamor E, . A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med 2004;351:23–32.
- Nieto G, Barber Y, Rubio MC, Rubio M, Fibla J. Association between AIDS disease progression rates and the Fok-I polymorphism of the VDR gene in a cohort of HIV-1 seropositive patients. J Steroid Biochem Mol Biol 2004;89–90:199–207.
- Mosekilde L, Brot C, Hyldstrup L, Mortensen LS, Molgard C, Rasmussen SE, . [The vitamin D status of the Danish population needs to be improved]. Ugeskr Laeger 2005;167:895–7.
- Holick MF, Chen TC, Lu Z, Sauter E. Vitamin D and skin physiology: a D-lightful story. J Bone Miner Res 2007;22(Suppl 2):V28–33.
- Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18–28.
- Teichmann J, Stephan E, Discher T, Lange U, Federlin K, Stracke H, . Changes in calciotropic hormones and biochemical markers of bone metabolism in patients with human immunodeficiency virus infection. Metabolism 2000;49:1134–9.
- Teichmann J, Stephan E, Lange U, Discher T, Friese G, Lohmeyer J, . Osteopenia in HIV-infected women prior to highly active antiretroviral therapy. J Infect 2003;46:221–7.
- Rodriguez M, Daniels B, Gunawardene S, Robbins GK. High frequency of vitamin D deficiency in ambulatory HIV-positive patients. AIDS Res Hum Retroviruses 2009;25:9–14.
- Hollis BW. Comparison of commercially available (125) I-based RIA methods for the determination of circulating 25-hydroxyvitamin D. Clin Chem 2000;46:1657–61.
- Lips P, Chapuy MC, Dawson-Hughes B, Pols HA, Holick MF. An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int 1999;9:394–7.
- Serrano S, Marinoso ML, Soriano JC, Rubies-Prat J, Aubia J, Coll J, . Bone remodelling in human immunodeficiency virus-1-infected patients. A histomorphometric study. Bone 1995;16:185–91.
- Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, Sweep FC, Hermus AR, Bosch ME, . Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008;24:1375–82.
- Madeddu G, Spanu A, Solinas P, Calia GM, Lovigu C, Chessa F, . Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Q J Nucl Med Mol Imaging 2004;48:39–48.
- Ramayo E, Gonzalez-Moreno MP, Macias J, Cruz-Ruiz M, Mira JA, Villar-Rueda AM, . Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active anti-retroviral therapy. AIDS Res Hum Retroviruses 2005;21:915–21.
- Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001;22:477–501.
- Brot C, Jorgensen N, Madsen OR, Jensen LB, Sorensen OH. Relationships between bone mineral density, serum vitamin D metabolites and calcium:phosphorus intake in healthy perimenopausal women. J Intern Med 1999;245:509–16.